Transcription factor JunB mRNA (JUNB)

Transcription factor JunB mRNA is the transcript of the JUNB gene, which encodes a protein that is a vital component of the Activator Protein-1 (AP-1) transcription factor complex (UniProt Consortium, 2023). This complex regulates a wide array of cellular processes, including cell growth, differentiation, and the stress response, by binding to specific DNA sequences in the promoter regions of target genes (NCBI Gene, 2024). JunB is characterized as an immediate-early gene, meaning its expression is rapidly induced in response to various stimuli such as growth factors and cytokines. In the context of disease, JunB is frequently dysregulated; its overexpression is a hallmark of several hematological malignancies, including multiple myeloma and certain lymphomas, where it contributes to cell survival and proliferation (Guerzoni et al., 2015). Additionally, JunB plays a role in the pathogenesis of inflammatory and fibrotic disorders, such as psoriasis and systemic sclerosis (Pap et al., 2004). Therapeutic strategies targeting JunB mRNA, primarily through RNA interference (RNAi) or antisense technologies, aim to reduce the levels of the JunB protein to treat these conditions, although such approaches are currently in the experimental or preclinical stages (Fan et al., 2021). Monitoring JunB mRNA levels can also serve as a biomarker for disease progression or therapeutic efficacy in clinical settings.

Other names

JunB proto-oncogeneAP-1 transcription factor subunit JunBJUNB

RNA interference (RNAi) or RNase H-mediated degradation of the target mRNA transcript to prevent protein translation.